Colinz Laboratories Share Price | Colinz Laboratories Stock Screener
COLINZ
Pharmaceuticals
Share Price BSE
₹77.55
▼
-4.08 (-5.00%)
As of July 3, 2026, the Colinz Laboratories share price (BSE: COLINZ) is ₹77.55, down 5.00% from the previous close, with shares trading between ₹77.55 and ₹77.55, and a 52-week range of ₹38.64–₹85.92.
Analyse COLINZ share price data and track historical price performance.
Use the Colinz Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Colinz Laboratories Market Cap
₹9.97 Cr.
COLINZ P/E Ratio (TTM)
18.52
Colinz Laboratories P/B Ratio
1.08
EPS (TTM)
₹2.04
Dividend Yield
-
Debt to Equity
0.07
COLINZ 52 Week High
₹85.92
Colinz Laboratories 52 Week Low
₹38.64
Operating Margin
7.00%
Profit Margin
16.67%
COLINZ Revenue (TTM)
₹6.00
EBITDA
-
Net Income
₹1.00
Total Assets
₹13.00
Total Equity
₹10.00
Colinz Laboratories Share Price Chart
Screen Colinz Laboratories share price with an interactive chart. Analyse COLINZ price trends and volatility across different timeframes.
Colinz Laboratories Company Profile - Fundamental Screener
Screen Colinz Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for COLINZ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE923C01011
Colinz Laboratories Balance Sheet Screener
Screen COLINZ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 13 | 12 | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 |
| Current Assets | 10 | 9 | 9 | 8 | 7 | 7 | 6 | 6 | 6 | 5 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 10 | 9 | 8 | 8 | 7 | 7 | 7 | 7 | 7 |
| Share Capital | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 8 | 7 | 6 | 6 | 4 | 4 | 3 | 3 | 3 | 3 |
Colinz Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Colinz Laboratories income statement and profit fundamentals.
Analyze COLINZ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Colinz Laboratories share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 7 | 7 | 7 | 7 | 6 | 8 | 8 | 8 | 8 | 8 | 8 |
| Expenses | 6 | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 7 |
| EBITDA | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 7.00% | 8.00% | 8.00% | 9.00% | 8.00% | 5.00% | 4.00% | 5.00% | 5.00% | 5.00% | 6.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 2.04 | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | -0.01 | 0.34 | 0.65 | 0.40 | 0.21 | 0.21 |
Colinz Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen COLINZ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Cash Flow | -2 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
Colinz Laboratories Shareholding Pattern Screener
See Colinz Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Colinz Laboratories promoter holding and ownership changes for COLINZ on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 31.22% | 31.01% | 30.97% | 31.04% | 30.44% | 31.01% | 31.04% | 30.95% |
| Other Holding | 2.78% | 2.99% | 3.03% | 2.95% | 3.56% | 2.99% | 2.96% | 3.05% |
| Shareholder Count | 3,250 | 3,212 | 3,272 | 3,238 | 3,216 | 3,202 | 3,116 | 2,980 |
Colinz Laboratories Share Dividend Screener - Share Yield Analysis
Check Colinz Laboratories dividend history with payout and yield data.
View Colinz Laboratories dividend details including ex-dates and amounts for COLINZ stock.
Colinz Laboratories Stock Index Membership
See which indices include Colinz Laboratories stock.
Check COLINZ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Colinz Laboratories Market Events Screener - Corporate Actions
Get Colinz Laboratories corporate actions including splits, bonuses, and buybacks.
Check Colinz Laboratories stock events that may affect COLINZ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.86% | ||
| Annual General Meeting | NA | -8.26% | ||
| 2026-04-29 | 2026-04-29 | Quarterly Result Announcement | NA | 0.00% |
| 2026-01-24 | 2026-01-24 | Quarterly Result Announcement | NA | -3.42% |
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | -1.94% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 12.74% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 13.57% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -3.37% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 4.60% |
Colinz Laboratories Competitors Screener - Peer Comparison
Screen COLINZ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,827 | 38.82 | 58,220 | 6.38% | 11,565 | 65.03 |
| Divis Laboratories | 174,081 | 69.38 | 10,560 | 8.73% | 2,520 | 43.32 |
| Torrent Pharmaceuticals | 157,634 | 71.51 | 13,886 | 20.34% | 2,138 | 66.05 |
| Cipla | 117,459 | 30.13 | 29,045 | 2.24% | 3,870 | 68.02 |
| Dr Reddys Laboratories | 114,822 | 27.10 | 33,593 | -0.44% | 3,998 | 73.77 |
| Zydus Life Science | 112,829 | 21.63 | 26,720 | 13.65% | 5,242 | 66.06 |
| Lupin | 110,115 | 20.00 | 27,488 | 19.98% | 5,345 | 66.98 |
| Mankind Pharma | 102,623 | 52.44 | 14,278 | 12.03% | 1,750 | 59.48 |
| Aurobindo Pharma | 89,879 | 25.78 | 33,385 | 3.21% | 3,376 | 65.10 |
| Laurus Labs | 80,995 | 88.02 | 6,868 | 22.01% | 890 | 70.64 |
Colinz Laboratories Company Announcements - News Screener
Screen COLINZ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-04 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Final Tranche Of Consideration Towards Sale Of Factory Undertaking | - |
| 2026-07-04 | Detailed Public Statement | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | - |
| 2026-06-18 | Open Offer - Public Announcement | - |
| 2026-06-11 | Clarification On Significant Movement In Share Price | - |
| 2026-06-01 | Clarification sought from Colinz Laboratories Ltd | - |
| 2026-05-26 | Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | - |
| 2026-05-26 | Submission Of Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | - |
| 2026-05-25 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-25 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-25 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-25 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-04-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-29 | Financial Results For The Quarter And Year Ended On 31-03-2026 | - |
| 2026-04-29 | Board Meeting Outcome for Disclosure Under Regulation 30 And Other Applicable Provisions Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)- Outcome Of The Board Meeting | - |
| 2026-04-29 | Integrated Filing (Financial) For The Quarter And Year Ended 31St March 2026 | - |
| 2026-04-24 | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | - |
| 2026-04-21 | Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015. | - |
| 2026-04-03 | Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations 2015 (Statement Of Deviation Or Variation For Proceeds Of Public Issue Rights Issue Preferential Issue QIP) For The Quarter Ended 31.03.2026 | - |
| 2026-04-03 | Non - Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of SEBI (LODR) Regulations 2015 (As Amended) Read With SEBI Circular No. CIR/CFD/CMD1/27/2019 Dated 8Th February 2019 BSE Circular Nos. LIST/COMP/10/2019-20 Dated 9Th May 201 | - |